Use App
Trending
News
Earnings
All
DIA
0.52%
SPY
0.14%
QQQ
0.11%
Trending
RACE
0.68%
ROBO
3.32%
WLD
16.75%
FCS
160.89%
ARTY
2.04%
HLIT
30.39%
AMP
0.08%
BN
0.18%
ALOY
0.41%
XCN
1.10%
RACE
0.68%
ROBO
3.32%
WLD
16.75%
FCS
160.89%
ARTY
2.04%
HLIT
30.39%
AMP
0.08%
BN
0.18%
ALOY
0.41%
XCN
1.10%
home
Symbol
LLYX
news
LLYX
Defiance Daily Target 2X Long LLY ETF
121
Volume
265,503.00
52W High
$28.44
52W Low
$9.60
50D MA
$18.01
Prev Close
$21.42
Loading...
Loading...
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
LLY Stock Surges On Q4 Beat – Obesity, Diabetes Drugs Drive Strong FY26 Outlook
Fourth-quarter revenue surged 43% to $19.3 billion, above Street estimates of $17.86 billion, according to Fiscal.ai data.
Full Article
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
The request applies to GLP-1 RAs approved for obesity, including Novo Nordisk’s Wegovy and Saxenda and Eli Lilly’s Zepbound.
Full Article
<
...
1
>
Compact View
Full View
Mini-Chart
Sentiment
Not available
Message Volume
Not available
Advertisement
|
Remove ads.
Latest LLYX News
View
LLY Stock Surges On Q4 Beat – Obesity, Diabetes Drugs Drive Strong FY26 Outlook
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
Top Discussions
top
active
trending
Loading...
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile